|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.55 GBX | +2.12% |
|
+1.10% | -15.75% |
| Dec. 09 | EMV Capital Portfolio Company Wanda Health Raises GBP1 Million | MT |
| Dec. 05 | EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations | AN |
| Capitalization | 12.06M 15.31M 14.6M 13.6M 21.72M 1.3B 23.99M 168M 62.36M 534M 57.55M 56.25M 2.33B | P/E ratio 2024 * |
-
| P/E ratio 2025 * | - |
|---|---|---|---|---|---|
| Enterprise value | -277M -352M -335M -312M -499M -29.85B -551M -3.86B -1.43B -12.27B -1.32B -1.29B -53.54B | EV / Sales 2024 * |
-0.1x | EV / Sales 2025 * | -0.47x |
| Free-Float |
57.28% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | +2.12% | ||
| 1 week | +1.10% | ||
| Current month | +17.56% | ||
| 1 month | +5.31% | ||
| 3 months | -8.92% | ||
| 6 months | -25.66% | ||
| Current year | -15.75% |
1 week
48.30
51.00
1 month
43.0053.00
Current year
43.0080.50
1 year
43.0080.50
3 years
42.22112.00
5 years
9.75210.00
10 years
9.752 150.00
| Director | Title | Age | Since |
|---|---|---|---|
Ilian Iliev
CEO | Chief Executive Officer | 48 | 2020-04-30 |
Stephen Crowe
DFI | Director of Finance/CFO | - | 2020-04-29 |
Edward Hooper
LAW | General Counsel | - | 2022-06-06 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ilian Iliev
BRD | Director/Board Member | 48 | 2019-10-13 |
Edward Hooper
BRD | Director/Board Member | - | 2022-12-08 |
| Chairman | 59 | 2023-01-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +2.12% | +1.10% | -19.76% | -53.84% | 15.31M | ||
| -0.85% | -1.31% | +23.27% | +17.19% | 3.11B | ||
| +76.23% | +73.89% | +68.57% | +72.08% | 2.97B | ||
| -.--% | -.--% | +12.82% | -29.60% | 1.77B | ||
| +0.21% | +0.54% | +11.28% | -42.52% | 1.43B | ||
| 0.00% | -1.81% | -33.08% | -56.72% | 921M | ||
| -0.08% | +0.63% | +34.33% | -65.31% | 741M | ||
| +1.51% | +2.62% | +5.37% | -9.46% | 618M | ||
| 0.00% | 0.00% | -7.83% | -7.55% | 504M | ||
| -1.69% | -6.23% | +25.27% | -13.79% | 451M | ||
| Average | +7.57% | +1.00% | +12.02% | -18.95% | 1.25B | |
| Weighted average by Cap. | +17.66% | +0.62% | +25.55% | +2.93% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.77B 3.52B 3.35B 3.12B 4.99B 298B 5.51B 38.63B 14.32B 123B 13.21B 12.92B 535B | 3.46B 4.4B 4.2B 3.91B 6.24B 373B 6.89B 48.34B 17.92B 154B 16.54B 16.16B 670B |
| Net income | - | - |
| Net Debt | -289M -367M -350M -326M -521M -31.15B -575M -4.03B -1.49B -12.8B -1.38B -1.35B -55.87B | -1.63B -2.07B -1.98B -1.84B -2.94B -176B -3.25B -22.78B -8.45B -72.36B -7.79B -7.62B -316B |
More financial data
* Estimated data
Employees
29
Calendar
2025-03-25
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-13 | 50.55 p | +2.12% | 18,000 |
| 24-12-12 | 49.50 p | 0.00% | 0 |
| 24-12-11 | 49.50 p | 0.00% | 24,876 |
| 24-12-10 | 49.50 p | 0.00% | 56,405 |
| 24-12-09 | 49.50 p | -1.00% | 15,000 |
Delayed Quote London S.E., December 13, 2024 at 06:23 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4950GBP
Average target price
1.490GBP
Spread / Average Target
+201.01%
Annual profits - Rate of surprise
- Stock Market
- Equities
- EMVC Stock